Prr Biotech Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 755.14%
- Profit Growth 133.83%
- Ebitda 164.54%
- Net Worth 45.65%
- Total Assets 243.14%
About Prr Biotech Innovations
Prr Biotech Innovations Private Limited (PBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 2013 and has a history of 11 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Amedawar, Ranjit Nagireddy, and Prathap Vutukuri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TG2013PTC089008
-
Company No.
089008
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jul 2013
-
Date of AGM
28 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Prr Biotech Innovations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Amedawar
|
Director | 17-Jul-2013 | Current |
|
Ranjit Nagireddy
|
Director | 17-Jul-2013 | Current |
|
Prathap Vutukuri
|
Director | 17-Jul-2013 | Current |
Financial Performance of Prr Biotech Innovations.
Prr Biotech Innovations Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 755.14% increase. The company also saw a substantial improvement in profitability, with a 133.83% increase in profit. The company's net worth Soared by an impressive increase of 45.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prr Biotech Innovations?
In 2017, Prr Biotech Innovations had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prasthan Agrotech Private LimitedRavi Amedawar, Ranjit Nagireddy and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prr Biotech Innovations?
Unlock and access historical data on people associated with Prr Biotech Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prr Biotech Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prr Biotech Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
